Researchbreadcrumb separatorPublicationsbreadcrumb separatorPeer-reviewedbreadcrumb separator2022
peer-reviewed Publications 2022
 
  1. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Mark N Polizzotto, Jacqueline Nordwall, Abdel G Babiker, Andrew Phillips, David M Vock, Nnakelu Eriobu, Vivian Kwaghe, Roger Paredes, Lourdes Mateu, Srikanth Ramachandruni, Rajeev Narang, Mamta K Jain, Susana M Lazarte, Jason V Baker, Anne E P Frosch, Garyfallia Poulakou, Konstantinos N Syrigos, Gretchen S Arnoczy, Natalie A McBride, Philip A Robinson, Farjad Sarafian, Sanjay Bhagani, Hassan S Taha, Thomas Benfield, Sean T H Liu, Anastasia Antoniadou, Jens Ulrik Stæhr Jensen, Ioannis Kalomenidis, Adityo Susilo, Prasetyo Hariadi, Tomas O Jensen Md, Jose Luis Morales-Rull, Marie Helleberg, Sreenath Meegada, Isik S Johansen, Daniel Canario, Eduardo Fernández-Cruz, Simeon Metallidis, Amish Shah, Aki Sakurai, Nikolaos G Koulouris, Robin Trotman, Amy C Weintrob, Daria Podlekareva, Usman Hadi, Kathryn M Lloyd, Birgit Thorup Røge, Sho Saito, Kelly Sweerus, Jakob J Malin, Christoph Lübbert, Jose Muñoz, Matthew J Cummings, Marcelo H Losso, Dan Turner, Kathryn Shaw-Saliba, Robin Dewar, Helene Highbarger, Perrine Lallemand, Tauseef Rehman, Norman Gerry, Dona Arlinda, Christina C Chang, Birgit Grund, Michael R Holbrook, Horace P Holley, Fleur Hudson, Laura A McNay, Daniel D Murray, Sarah L Pett, Megan Shaughnessy, Mary C Smolskis, Giota Touloumi, Mary E Wright, Mittie K Doyle, Sharon Popik, Christine Hall, Roshan Ramanathan, Huyen Cao, Elsa Mondou, Todd Willis, Joseph V Thakuria, Leman Yel, Elizabeth Higgs, Virginia L Kan, Jens D Lundgren, James D Neaton, H Clifford Lane on behalf of ITAC (INSIGHT 013) Study Group.
    Lancet. 2022:S0140-6736(22)00101-5. Abstract
     
  2. Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting. Greenberg L, Ryom L, Neesgaard B, Miró JM, Dahlerup Rasmussen L, Zangerle R, Grabmeier-Pfistershammer K, Günthard HF, Kusejko K, Smith C, Mussini C, Menozzi M, Wit F, Van Der Valk M, d'Arminio Monforte A, De Wit S, Necsoi C, Pelchen-Matthews A, Lundgren J, Peters L, Castagna A, Muccini C, Vehreschild JJ, Pradier C, Bruguera Riera A, Sönnerborg A, Petoumenos K, Garges H, Rogatto F, Dedes N, Bansi-Matharu L, Mocroft A; RESPOND Study Group.
    Open Forum Infect Dis. 2022;9(3):ofac029. Abstract
     
  3. Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients. Crone CG, Rezahosseini O, Schultz HHL, Qvist T, Johansen HK, Nielsen SD, Perch M.
    Pathogens. 2022;11(2):181. Abstract
     
  4. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis. Andreasen PB, Rezahosseini O, Møller DL, Wareham NE, Thomsen MT, Houmami R, Knudsen AD, Knudsen J, Kurtzhals JAL, Rostved AA, Pedersen CR, Rasmussen A, Nielsen SD.
    Immun Inflamm Dis. 2022;10(1):93-100. Abstract
     
  5. Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals. Olund Villumsen S, Benfeitas R, Knudsen AD, Gelpi M, Høgh J, Thomsen MT, Murray D, Ullum H, Neogi U, Nielsen SD.
    Front Immunol. 2022;12:742736. Abstract
     
  6. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. Byonanebye DM, Polizzotto MN, Neesgaard B, Sarcletti M, Matulionyte R, Braun DL, Castagna A, de Wit S, Wit F, Fontas E, Vehreschild JJ, Vesterbacka J, Greenberg L, Hatleberg C, Garges H, Gallant J, Volny Anne A, Öllinger A, Mozer-Lisewska I, Surial B, Spagnuolo V, Necsoi C, van der Valk M, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group.
    HIV Med. 2022. Epub ahead of print. Abstract
     
  7. Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort. Dos Santos Q, Hornum M, Terrones-Campos C, Crone CG, Wareham NE, Soeborg A, Rasmussen A, Gustafsson F, Perch M, Soerensen SS, Lundgren J, Feldt-Rasmussen B, Reekie J.
    Transpl Int. 2022;35:10352. Abstract
     
  8. Risk of Bacterial, Viral, and Fungal Infections in Patients With Solid Malignant Tumors Treated With Curative Intent Radiation Therapy. Terrones-Campos C, Ledergerber B, Specht L, Vogelius IR, Helleberg M, Lundgren J.
    Adv Radiat Oncol. 2022;7(6):100950. Abstract
     
  9. Patients with CLL have lower risk of death from COVID-19 in the omicron era. Niemann CU, da Cunha-Bang C, Helleberg M, Ostrowski SR, Brieghel C.
    Blood. 2022:blood.2022016147. Abstract
     
  10. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium Neesgaard B, Greenberg L, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, d'Arminio Monforte A, Vehreschild JJ, Sönnerborg A, Anne AV, Carr A, Bansi-Matharu L, Lundgren JD, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Necsoi C, van der Valk M, Menozzi M, Muccini C, Peters L, Mocroft A, Ryom L.
    Lancet HIV. 2022:S2352-3018(22)00094-7. Abstract
     
  11. The gut microbiome in patients with chronic lymphocytic leukemia. Faitová T, Svanberg R, Da Cunha-Bang C, Ilett EE, Jørgensen M, Noguera-Julian M, Paredes R, MacPherson CR, Niemann CU.
    Haematologica. 2022. Epub ahead of print. Abstract
     
  12. Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours. Roen A, Terrones C, Bannister W, Helleberg M, Andersen MA, Niemann CU, Daugaard G, Specht L, Mocroft A, Reekie J, Lundgren J.
    Infection. 2022. Epub ahead of print. Abstract
     
  13. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients. Dos Santos Q, Wareham NE, Mocroft A, Rasmussen A, Gustafsson F, Perch M, Sørensen SS, Manuel O, Müller NJ, Lundgren J, Reekie J.
    Cancers (Basel). 2022;14(13):3279. Abstract
     
  14. Early- and late-onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients. Abdulovski R, Møller DL, Knudsen AD, Sørensen SS, Rasmussen A, Nielsen SD, Wareham NE.
    Eur J Haematol. 2022. Epub ahead of print. Abstract
     
  15. Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population. Gjesdal G, Lundgren J, Czuba T, Wareham NE, Gustafsson F, Nilsson J, Smith JG, Braun OÖ.
    Clin Transplant. 2022:e14756. Epub ahead of print. Abstract
     
  16. Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death. Søborg A, Reekie J, Rasmussen A, Cunha-Bang CD, Gustafsson F, Rossing K, Perch M, Krohn PS, Sørensen SS, Lund TK, Sørensen VR, Ekenberg C, Lundgren L, Lodding IP, Moestrup KS, Lundgren J, Wareham NE.
    PLoS One. 2022;17(7):e0263210. Abstract
     
  17. Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study.  Søgaard OS, Reekie J, Johansen IS, Nielsen H, Benfield T, Wiese L, Stærke NB, Iversen K, Fogh K, Bodilsen J, Iversen M, Knudsen LS, Klastrup V, Larsen FD, Andersen SD, Hvidt AK, Andreasen SR, Madsen LW, Lindvig SO, Øvrehus A, Ostrowski SR, Abildgaard C, Matthews C, Jensen TO, Raben D, Erikstrup C, Fischer TK, Tolstrup M, Østergaard L, Lundgren J; ENFORCE Writing Group.
    Clin Microbiol Infect. 2022;28(8):1126-1133 Abstract
     
  18. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections. Stærke NB, Reekie J, Nielsen H, Benfield T, Wiese L, Knudsen LS, Iversen MB, Iversen K, Fogh K, Bodilsen J, Juhl MR, Lindvig SO, Øvrehus A, Madsen LW, Klastrup V, Andersen SD, Juhl AK, Andreasen SR, Ostrowski SR, Erikstrup C, Fischer TK, Tolstrup M, Østergaard L, Johansen IS, Lundgren J, Søgaard OS.
    Nat Commun. 2022;13(1):4466. Abstract
     
  19. Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. Adit A Ginde, Roger Paredes, Thomas A Murray, Nicole Engen, Greg Grandits, Andrew Vekstein, Noel Ivey, Ahmad Mourad, Uriel Sandkovsky, Robert L Gottlieb, Mezgebe Berhe, Mamta K Jain, Rubria Marines-Price, Barbine Tchamba Agbor Agbor, Lourdes Mateu, Sergio España-Cueto, Gemma Lladós, Eleftherios Mylonakis, Ralph Rogers, Fadi Shehadeh, Michael R Filbin, Kathryn A Hibbert, Kami Kim, Thanh Tran, Peter E Morris, Evan P Cassity, Barbara Trautner, Lavannya M Pandit, Kirk U Knowlton, Lindsay Leither, Michael A Matthay, Angela J Rogers, Wonder Drake, Beatrice Jones, Garyfallia Poulakou, Konstantinos N Syrigos, Eduardo Fernández-Cruz, Marisa Di Natale, Eyad Almasri, Leire Balerdi-Sarasola, Sanjay R Bhagani, Katherine L Boyle, Jonathan D Casey, Peter Chen, David J Douin, D Clark Files, Huldrych F Günthard, R Duncan Hite, Robert C Hyzy, Akram Khan, Moses Kibirige, Robert Kidega, Francis Kiweewa, Jens-Ulrik Jensen, Bradley G Leshnower, Joseph K Lutaakome, Prasad Manian, Vidya Menon, Jose Luis Morales-Rull, D Shane O'Mahony, J Scott Overcash, Srikant Ramachandruni, Jay S Steingrub, Hassan S Taha, Michael Waters, Barnaby E Young, Andrew N Phillips, Daniel D Murray, Tomas O Jensen, Maria L Padilla, David Sahner, Katy Shaw-Saliba, Robin L Dewar, Marc Teitelbaum, Ven Natarajan, M Tauseef Rehman, Sarah Pett, Fleur Hudson, Giota Touloumi, Samuel M Brown, Wesley H Self, Christina C Chang, Adriana Sánchez, Amy C Weintrob, Timothy Hatlen, Birgit Grund, Shweta Sharma, Cavan S Reilly, Pedro Garbes, Mark T Esser, Alison Templeton, Abdel G Babiker, Victoria J Davey, Annetine C Gelijns, Elizabeth S Higgs, Virginia Kan, Gail Matthews, B Taylor Thompson, James D Neaton, H Clifford Lane, Jens D Lundgren on behalf of ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
    Lancet Respir Med. 2022:S2213-2600(22)00215-6. Abstract
     
  20. Observational cohort study of rilpivirine (RPV) utilization in Europe. Cozzi-Lepri A, Peters L, Pelchen-Matthews A, Neesgaard B, De Wit S, Johansen IS, Edwards S, Stephan C, Adamis G, Staub T, Zagalo A, Domingo P, Elbirt D, Kusejko K, Brännström J, Paduta D, Trofimova T, Szlavik J, Zilmer K, Losso M, Van Eygen V, Pai H, Lundgren J, Mocroft A; EuroSIDA Study Group.
    AIDS Res Ther. 2022;19(1):38. Abstract
     
  21. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. ACTIV-3/TICO Study Group; Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM, Rogers R, Shehadeh F, Kaczynski M, Mylona EK, Syrigos KN, Rapti V, Lye DC, Hui DS, Leither L, Knowlton KU, Jain MK, Marines-Price R, Osuji A, Overcash JS, Kalomenidis I, Barmparessou Z, Waters M, Zepeda K, Chen P, Torbati S, Kiweewa F, Sebudde N, Almasri E, Hughes A, Bhagani SR, Rodger A, Sandkovsky U, Gottlieb RL, Nnakelu E, Trautner B, Menon V, Lutaakome J, Matthay M, Robinson P, Protopapas K, Koulouris N, Kimuli I, Baduashvili A, Braun DL, Günthard HF, Ramachandruni S, Kidega R, Kim K, Hatlen TJ, Phillips AN, Murray DD, Jensen TO, Padilla ML, Accardi EX, Shaw-Saliba K, Dewar RL, Teitelbaum M, Natarajan V, Laverdure S, Highbarger HC, Rehman MT, Vogel S, Vallée D, Crew P, Atri N, Schechner AJ, Pett S, Hudson F, Badrock J, Touloumi G, Brown SM, Self WH, North CM, Ginde AA, Chang CC, Kelleher A, Nagy-Agren S, Vasudeva S, Looney D, Nguyen HH, Sánchez A, Weintrob AC, Grund B, Sharma S, Reilly CS, Paredes R, Bednarska A, Gerry NP, Babiker AG, Davey VJ, Gelijns AC, Higgs ES, Kan V, Matthews G, Thompson BT, Legenne P, Chandra R, Lane HC, Neaton JD, Lundgren JD.
    Ann Intern Med. 2022. Epub ahead of print. Abstract
     
  22. Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. ACTIV-3/TICO Bamlanivimab Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Goodman AL, Chang W, Dewar RL, Gerry NP, Higgs ES, Highbarger H, Murray DD, Murray TA, Natarajan V, Paredes R, Parmar MKB, Phillips AN, Reilly C, Rupert AW, Sharma S, Shaw-Saliba K, Sherman BT, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Davey VJ, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD.
    Ann Intern Med. 2022;175(2):234-243. Abstract
     
  23. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Wesley H Self WH, Uriel Sandkovsky, Cavan S Reilly, David M Vock, Robert L Gottlieb, Michael Mack, Kevin Golden, Emma Dishner, Andrew Vekstein, Emily R Ko, Tatyana Der, John Franzone, Eyad Almasri, Mohamed Fayed, Michael R Filbin, Kathryn A Hibbert, Todd W Rice, Jonathan D Casey, J Awori Hayanga, Vinay Badhwar, Bradley G Leshnower, Milad Sharifpour, Kirk U Knowlton, Ithan D Peltan, Elizieta Bakowska, Justyna Kowalska, Michael E Bowdish, Jeffrey M Sturek, Angela J Rogers, D Clark Files, Jarrod M Mosier, Michelle N Gong, David J Douin, R Duncan Hite, Barbara W Trautner, Mamta K Jain, Edward M Gardner, Akram Khan, Jens-Ulrik Jensen, Michael A Matthay, Adit A Ginde, Samuel M Brown, Elizabeth S Higgs, Sarah Pett, Amy C Weintrob, Christina C Chang, Daniel D Murray, Huldrych F Günthard, Ellen Moquete, Greg Grandits, Nicole Engen, Birgit Grund, Shweta Sharma, Huyen Cao, Rajesh Gupta, Suzette Osei, David Margolis, Qing Zhu, Mark N Polizzotto, Abdel G Babiker, Victoria J Davey, Virginia Kan, B Taylor Thompson, Annetine C Gelijns, James D Neaton, H Clifford Lane, Jens D Lundgren on behalf of ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
    Lancet Infect Dis. 2022;22(5):622-635. Abstract
     
  24. Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery. Douin DJ, Siegel L, Grandits G, Phillips A, Aggarwal NR, Baker J, Brown SM, Chang CC, Goodman AL, Grund B, Higgs ES, Hough CL, Murray DD, Paredes R, Parmar M, Pett S, Polizzotto MN, Sandkovsky U, Self WH, Young BE, Babiker AG, Davey VJ, Kan V, Gelijns AC, Matthews G, Thompson BT, Lane HC, Neaton JD, Lundgren JD, Ginde AA; ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
    Am J Respir Crit Care Med. 20227. Epub ahead of print. Abstract
     
  25. RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19. Wick KD, Siegel L, Neaton JD, Oldmixon C, Lundgren J, Dewar RL, Lane HC, Thompson BT, Matthay MA; ACTIV-3/TICO study group.
    JCI Insight. 2022;7(9):e157499. Abstract
     
  26. Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study. Nikolaichuk M, Mocroft A, Wandeler G, Szlavik J, Gottfredsson M, Reikvam DH, Svedhem V, Elinav H, Laguno M, Mansinho K, Devitt E, Chkhartishvili N, Behrens G, Bogner J, Viard JP, Winston A, Benfield T, Leen C, Fursa O, Rockstroh J, Peters L; EuroSIDA study group.
    HIV Med. 2022. Epub ahead of print. Abstract
     
  27. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens. Bannister WP, Mast TC, de Wit S, Gerstoft J, Wiese L, Milinkovic A, Hadziosmanovic V, Clarke A, Rasmussen LD, Lacombe K, Schommers P, Staub T, Zagalo A, Portu JJ, Tau L, Calmy A, Cavassini M, Gisinger M, Borodulina E, Mocroft A, Reekie J, Peters L; EuroSIDA study group.
    AIDS. 2022. Epub ahead of print. Abstract
     
  28. Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO). Mylonakis E, Lutaakome J, Jain MK, Rogers AJ, Moltó J, Benet S, Mourad A, Files DC, Mugerwa H, Kityo C, Kiweewa F, Nalubega MG, Kitonsa J, Nabenkema E, Murray DD, Braun D, Kamel D, Higgs ES, Hatlen TJ, Kan VL, Sanchez A, Tierney J, Denner E, Wentworth D, Babiker AG, Davey VJ, Gelijns AC, Matthews GV, Thompson BT, Lane HC, Neaton JD, Lundgren JD.
    Med (N Y). 2022;3(8):531-537. Abstract
     
  29. Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. Zucco AG, Agius R, Svanberg R, Moestrup KS, Marandi RZ, MacPherson CR, Lundgren J, Ostrowski SR, Niemann CU.
    Sci Rep. 2022;12(1):13879. Abstract
     
  30. Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.  Moestrup KS, Reekie J, Zucco AG, Jensen TØ, Jensen JUS, Wiese L, Ostrowski SR, Niemann CU, MacPherson C, Lundgren J, Helleberg M.
    Clin Infect Dis. 2022:ciac639. Epub ahead of print. Abstract
     
  31. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. ACTIV-3/TICO Study Group; Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Chang W, Dharan NJ, Davey VJ, Higgs ES, Gerry N, Ginde AA, Hayanga JWA, Highbarger H, Highbarger JL, Jain MK, Kan V, Kim K, Lallemand P, Leshnower BG, Lutaakome JK, Matthews G, Mourad A, Mylonakis E, Natarajan V, Padilla ML, Pandit LM, Paredes R, Pett S, Ramachandruni S, Rehman MT, Sherman BT, Files DC, Brown SM, Matthay MA, Thompson BT, Neaton JD, Lane HC, Lundgren JD. .
    Ann Intern Med. 2022. Epub ahead of print. Epub ahead of print. Abstract
     
  32. Low spontaneous clearance rates of recently acquired hepatitis C virus in HIV-positive MSM (The PROBE-C Study). Monin MB, Ingiliz P, Lutz T, Scholten S, Cordes C, Martínez-Rebollar M, Spinner CD, Nelson M, Rausch M, Bhagani S, Peters L, Reiberger T, Mauss S, Rockstroh JK, Boesecke C; PROBE-C study group.
    Clin Infect Dis. 2022:ciac680. Abstract
     
  33. Uptake of the lateral flow urine LAM test in Europe and Central Asia. Kraef C, Yedilbayev A, Seguy N, Bentzon A, Podlekareva D, Cirillo DM, van der Werf MJ, Kirk O.
    Int J Tuberc Lung Dis. 2022;26(9):835-841. Abstract
     
  34. Diagnostic toolkit for tuberculosis: should we include urine lipoarabinomannan (LAM) detection in the WHO European Region? Kraef C, Lindquist E, Svensson E, Cambau E.
    Clin Microbiol Infect. 2022:S1198-743X(22)00336-6. Abstract
     
  35. Monitoring progress towards elimination of hepatitis B and C in the EU/EEA. Sharrock KC, Noori T, Axelsson M, Buti M, Diaz A, Fursa O, Hendrickx G, James J, Klavs I, Korenjak M, Maticic M, Mozalevskis A, Peters L, Rigoni R, Rosinska M, Ruutel K, Eberhard Schatz, Thomas Seyler, Irene Veldhuijzen, Duffell E.
    PLOS Glob Public Health. 2022; 2(8): e0000841. Abstract
     
  36. Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV. Jaschinski N, Greenberg L, Neesgaard B, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, Monforte A, Vehreschild J, Sönnerborg A, Anne AV, Carr A, Bansi-Matharu L, Lundgren J, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Nescoi C, Van Der Valk M, Menozzi M, Muccini C, Mocroft A, Peters L, Ryom L; RESPOND Study Group.
    AIDS. 2022. Epub ahead of print.Abstract
     
  37. Post-Transplantation Anemia and Risk of Death Following Lung Transplantation. Bugge TB, Perch M, Rezahosseini O, Crone CG, Jensen K, Schultz HH, Bredahl P, Hornum M, Nielsen SD, Lund TK.
    Transplant Proc. 2022:S0041-1345(22)00508-5. Abstract
     
  38. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling. Mørup SB, Nazaryan-Petersen L, Gabrielaite M, Reekie J, Marquart HV, Hartling HJ, Marvig RL, Katzenstein TL, Masmas TN, Lundgren J, Murray DD, Helleberg M, Borgwardt L.
    Front Immunol. 2022;13:906328. Abstract
     
  39. Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Jørgensen M, Nørgaard JC, Ilett EE, Marandi RZ, Noguera-Julian M, Paredes R, Murray DD, Lundgren J, MacPherson CR, Sengeløv H.
    Int J Mol Sci. 2022;23(19):11115. Abstract
     
  40. Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in persons living with HIV. Tusch ES, Ryom L, Fursa O, Peters L, Oestergaard L, Florence E, Edwards S, Hoffmann C, Sambatakou H, Reiss P, Shahar E, Reikvam DH, Schmied B, Paduta D, Yakovlev A, Szlávik J, Ranin J, Zilmer K, Uždaviniene V, Pelchen-Matthews A, Mocroft A, Reekie J.
    AIDS. 2022. Epub ahead of print. Abstract
     
  41. Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection. Begré L, Béguelin C, Boyd A, Peters L, Rockstroh J, Günthard HF, Bernasconi E, Cavassini M, Lacombe K, Mocroft A, Wandeler G, Rauch A.
    Front Med (Lausanne). 2022;9:988356. Abstract
     
  42. Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines. Hvidt AK, Baerends EAM, Søgaard OS, Stærke NB, Raben D, Reekie J, Nielsen H, Johansen IS, Wiese L, Benfield TL, Iversen KK, Mustafa AB, Juhl MR, Petersen KT, Ostrowski SR, Lindvig SO, Rasmussen LD, Schleimann MH, Andersen SD, Juhl AK, Dietz LL, Andreasen SR, Lundgren J, Østergaard L, Tolstrup M; ENFORCE Study Group.
    Front Med (Lausanne). 2022;9:994160. Abstract
     
  43. Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score. CJensen CM, Costa JC, Nørgaard JC, Zucco AG, Neesgaard B, Niemann CU, Ostrowski SR, Reekie J, Holten B, Kalhauge A, Matthay MA, Lundgren JD, Helleberg M, Moestrup KS.
    Sci Rep. 2022;12(1):21019.  Abstract
     
  44. Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study. Isfordink C, Boyd A, Mocroft A, Kusejko K, Smit C, de Wit S, Mahungu T, Falconer K, Wandeler G, Cavassini M, Stöckle M, Schinkel J, Rauch A, Peters L, van der Valk M; for EuroSIDA, the Swiss HIV Cohort Study, and the ATHENA Observational Cohort.
    Open Forum Infect Dis. 2022;9(10):ofac508. Abstract
     
  45. Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population. Bollerup S, Engsig F, Hallager S, Mocroft A, Roege BT, Christensen PB, Laursen AL, Krarup H, Clausen MR, Thielsen P, Madsen LG, Noerregaard L, Barfod TS, Balslev U, Tarp B, Hansen JB, Mygind LH, Gerstoft J, Weis N.
    J Hepatocell Carcinoma. 2022;9:1093-1104. Abstract
     
  46. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe. Mocroft A, Geressu A, Beguelin C, Llibre JM, Lazarus JV, Tomazic J, Smidt J, Parczewski M, Brännström J, Sedlacek D, Degen O, van der Valk M, Paduta D, Flamholc L, Schmid P, Orkin C, Nielsen LN, Hoffmann C, Beniowski M, Oprea C, Begovac J, Peters L.
    AIDS. 2022. Epub ahead of print. Abstract
     
  47. National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review. Jordans CCE, Vasylyev M, Rae C, Jakobsen ML, Vassilenko A, Dauby N, Grevsen AL, Jakobsen SF, Raahauge A, Champenois K, Papot E, Malin JJ, Boender TS, Behrens GMN, Gruell H, Neumann A, Spinner CD, Valbert F, Akinosoglou K, Kostaki EG, Nozza S, Giacomelli A, Lapadula G, Mazzitelli M, Torti C, Matulionyte R, Matulyte E, Van Welzen BJ, Hensley KS, Thompson M, Ankiersztejn-Bartczak M, Skrzat-Klapaczyńska A, Săndulescu O, Streinu-Cercel A, Streinu-Cercel A, Miron VD, Pokrovskaya A, Hachfeld A, Dorokhina A, Sukach M, Lord E, Sullivan AK, Rokx C; on behalf of the Guidelines Review Group for the projects: Optimising testing and linkage to care for HIV across Europe (OptTEST by HiE) and the Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and STIs in Europe (INTEGRATE).
    Euro Surveill. 2022;27(48):2200338. Abstract
     
  48. A call to action to reclaim focus on testing and early treatment for HIV, viral hepatitis, sexually transmitted infections and tuberculosis. Stengaard AR, Raben D, Leite RB, Seyler T, Lazarus JV, Lambert J, Collins B, Attawell K, Raahauge A, Rockstroh JK, Simões D; 2021 HepHIV Conference Organising Committee and the EuroTEST Steering Committee.
    Int J STD AIDS. 2022;33(10):943-948.  Abstract
     
  49. Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE). Stærke NB, Reekie J, Johansen IS, Nielsen H, Benfield T, Wiese L, Søgaard OS, Tolstrup M, Iversen KK, Tarp B, Larsen FD, Larsen L, Lindvig SO, Holden IK, Iversen MB, Knudsen LS, Fogh K, Jakobsen ML, Traytel AK, Ostergaard L, Lundgren J; ENFORCE Study Group.
    BMJ Open. 2022;12(12):e069065. Abstract
     
  50. Adverse Events Associated with Universal versus Targeted Antifungal Prophylaxis among Lung Transplant Recipients-A Nationwide Cohort Study 2010-2019. Crone CG, Wulff SM, Helweg-Larsen J, Bredahl P, Arendrup MC, Perch M, Helleberg M.
    Microorganisms. 2022;10(12):2478.Abstract
     
  51. Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer. Front Immunol. Ryssel H, Egebjerg K, Nielsen SD, Lundgren J, Pøhl M, Langer SW, Kjaer A, Ostrowski SR, Fischer BM.
    Front Immunol. 2022;13:1024224. Abstract
     
  52. Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome. Zargari Marandi R, Jørgensen M, Ilett EE, Nørgaard JC, Noguera-Julian M, Paredes R, Lundgren JD, Sengeløv H, MacPherson CR.
    Cells. 2022;11(24):4089. Abstract
     
  53. Association between TET2 genetic variation and viral load in people living with HIV. Murray DD, Grund B, MacPherson C, Ekenberg C, Zucco A, Reekie J, Dominguez-Dominguez L, Leung P, Fusco D, Gras J, Gerstoft J, Helleberg M, Borges ÁH, Polizzotto M, Lundgren JD; INSIGHT START, SMART, ESPRIT, STALWART study groups, the FIRST study group.
    AIDS. 2022. Epub ahead of print. Abstract
     
  54. Late diagnosis of HIV: An updated consensus definition. Croxford S, Stengaard AR, Brännström J, Combs L, Dedes N, Girardi E, Grabar S, Kirk O, Kuchukhidze G, Lazarus JV, Noori T, Pharris A, Raben D, Rockstroh JK, Simões D, Sullivan AK, Van Beckhoven D, Delpech VC; EuroTEST HIV Late Diagnosis Definition Working Group.
    HIV Med. 2022;23(11):1202-1208. Abstract
     
Login